Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Cladribine, High-dose Cytarabine and Idarubicin in Patients With Relapsed Acute Myeloid Leukemia

NCT00126321 is registered in ClinicalTrials.gov with University Hospital, Bonn as lead sponsor.

NCT NCT00126321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00126321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Cladribine, High-dose Cytarabine and Idarubicin in Patients With Relapsed Acute Myeloid Leukemia
Lead sponsor
University Hospital, Bonn
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2004
Completion date
March 31, 2011
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myelocytic, acute